Sensitive and simultaneous surface plasmon resonance detection of free and p53-bound MDM2 proteins from human sarcomas

被引:8
作者
Wu, Ling [1 ]
Tang, Hailin [2 ]
Hu, Shengqiang [1 ]
Xia, Yonghong [1 ]
Lu, Zhixuan [1 ]
Fan, Yujuan [1 ]
Wang, Zixiao [1 ]
Yi, Xinyao [1 ]
Zhou, Feimeng [3 ]
Wang, Jianxiu [1 ]
机构
[1] Cent S Univ, Coll Chem & Chem Engn, Changsha 410083, Hunan, Peoples R China
[2] SunYat Sen Univ, Ctr Canc, State Key Lab Oncol South China, Collaborat Innovat Ctr Canc Med, Guangzhou 510060, Guangdong, Peoples R China
[3] Calif State Univ Los Angeles, Dept Chem & Biochem, Los Angeles, CA 90032 USA
基金
美国国家科学基金会; 中国国家自然科学基金;
关键词
P53; TUMOR-SUPPRESSOR; ONCOPROTEIN MDM2; CANCER; OVEREXPRESSION; AMPLIFICATION; DEGRADATION; ACTIVATION; TRANSACTIVATION; UBIQUITINATION; INHIBITION;
D O I
10.1039/c7an01918a
中图分类号
O65 [分析化学];
学科分类号
070302 ; 081704 ;
摘要
Murine double minute 2 (MDM2) is an oncoprotein mediating the degradation of the tumor suppressor p53 protein. The physiological levels of MDM2 protein are closely related to malignant transformation and tumor growth. In this work, the simultaneous and label-free determination of free and p53-bound MDM2 proteins from sarcoma tissue extracts was conducted using a dual-channel surface plasmon resonance (SPR) instrument. Free MDM2 protein was measured in one fluidic channel covered with the consensus double-stranded (ds)-DNA/p53 conjugate, while MDM2 bound to p53 was captured by the consensus dsDNA immobilized onto the other channel. To achieve higher sensitivity and to confirm specificity, an MDM2-specific monoclonal antibody (2A10) was used to recognize both the free and p53-bound MDM2 proteins. The resultant method afforded a detection limit of 0.55 pM of MDM2. The amenability of the method to the analysis of free and p53-bound MDM2 proteins was demonstrated for normal and sarcoma tissue extracts from three patients. Our data reveal that both free and total MDM2 (free and bound forms combined) proteins from sarcoma tissue extracts are of much higher concentrations than those from normal tissue extracts and the p53-bound MDM2 protein only constitutes a small fraction of the total MDM2 concentration. In comparison with enzyme-linked immunosorbent assay (ELISA), the proposed method possesses higher sensitivity, is more cost-effective, and is capable of determining free and p53-bound MDM2 proteins in clinical samples.
引用
收藏
页码:2029 / 2034
页数:6
相关论文
共 42 条
[1]   Awakening guardian angels: drugging the p53 pathway [J].
Brown, Christopher J. ;
Lain, Sonia ;
Verma, Chandra S. ;
Fersht, Alan R. ;
Lane, David P. .
NATURE REVIEWS CANCER, 2009, 9 (12) :862-873
[2]   Biochemical uncovering of mdm2/p53 complexes in liposarcomas parallels their immunohistochemical detection [J].
Butò, S ;
Pierotti, MA ;
Tamborini, E ;
Della Torre, G ;
Lavarino, C ;
Rilke, F ;
Pilotti, S .
DIAGNOSTIC MOLECULAR PATHOLOGY, 1999, 8 (03) :125-130
[3]   MAPPING OF THE P53 AND MDM-2 INTERACTION DOMAINS [J].
CHEN, JD ;
MARECHAL, V ;
LEVINE, AJ .
MOLECULAR AND CELLULAR BIOLOGY, 1993, 13 (07) :4107-4114
[4]   Label-free impedimetric immunosensor for ultrasensitive detection of cancer marker Murine double minute 2 in brain tissue [J].
Elshafey, Reda ;
Tlili, Chaker ;
Abulrob, Abedelnasser ;
Tavares, Ana C. ;
Zourob, Mohammed .
BIOSENSORS & BIOELECTRONICS, 2013, 39 (01) :220-225
[5]   THE MDM-2 ONCOGENE CAN OVERCOME WILD-TYPE P53 SUPPRESSION OF TRANSFORMED-CELL GROWTH [J].
FINLAY, CA .
MOLECULAR AND CELLULAR BIOLOGY, 1993, 13 (01) :301-306
[6]   A highly sensitive fluorescent light-up probe for real-time detection of the endogenous protein target and its antagonism in live cells [J].
Geng, Junlong ;
Goh, Walter L. ;
Zhang, Chongjing ;
Lane, David P. ;
Liu, Bin ;
Ghadessy, Farid ;
Tan, Yen Nee .
JOURNAL OF MATERIALS CHEMISTRY B, 2015, 3 (29) :5933-5937
[7]   Overexpression of Mdm2 and MdmX fusion proteins alters p53 mediated transactivation, ubiquitination, and degradation [J].
Ghosh, M ;
Huang, K ;
Berberich, SJ .
BIOCHEMISTRY, 2003, 42 (08) :2291-2299
[8]   Specific p53-DNA complexes contain an mdm2-related protein [J].
Hall, AR ;
Milner, J .
ONCOGENE, 1997, 14 (11) :1371-1376
[9]   High expressions of LDHA and AMPK as prognostic biomarkers for breast cancer [J].
Huang, Xiaojia ;
Li, Xing ;
Xie, Xinhua ;
Ye, Feng ;
Chen, Bo ;
Song, Cailu ;
Tang, Hailin ;
Xie, Xiaoming .
BREAST, 2016, 30 :39-46
[10]  
Iwakuma T, 2003, MOL CANCER RES, V1, P993